| State, largest PBM | Market share in state |
|---|---|
| Alabama, Prime Therapeutics | 86% |
| Alaska, Express Scripts | 75% |
| Arizona, OptumRx | 53% |
| Arkansas, CVS/Caremark | 49% |
| California, Kaiser Pharmacy | 48% |
| Colorado, Kaiser Pharmacy | 26% |
| Connecticut, Express Scripts | 36% |
| Delaware, Express Scripts | 78% |
| District of Columbia, CVS/Caremark | 35% |
| Florida, Prime Therapeutics | 42% |
| Georgia, IngenioRx | 30% |
| Hawaii, CVS/Caremark | 64% |
| Idaho, CVS/Caremark | 54% |
| Illinois, Prime Therapeutics | 59% |
| Indiana, IngenioRx | 50% |
| Iowa, CVS/Caremark | 61% |
| Kansas, Prime Therapeutics | 47% |
| Kentucky, IngenioRx | 59% |
| Louisiana, Express Scripts | 71% |
| Maine, IngenioRx | 56% |
| Maryland, CVS/Caremark | 39% |
| Massachusetts, CVS/Caremark | 58% |
| Michigan, Express Scripts | 89% |
| Minnesota, Prime Therapeutics | 51% |
| Mississippi, Prime Therapeutics | 49% |
| Missouri, OptumRx | 39% |
| Montana, Prime Therapeutics | 51% |
| Nebraska, Prime Therapeutics | 46% |
| Nevada, OptumRx | 47% |
| New Hampshire, IngenioRx | 52% |
| New Jersey, Prime Therapeutics | 35% |
| New Mexico, Prime Therapeutics | 46% |
| New York, Express Scripts | 35% |
| North Carolina, Prime Therapeutics | 58% |
| North Dakota, Prime Therapeutics | 57% |
| Ohio, Express Scripts | 38% |
| Oklahoma, Prime Therapeutics | 57% |
| Oregon, Kaiser Pharmacy | 36% |
| Pennsylvania, Express Scripts | 47% |
| Rhode Island, Prime Therapeutics | 53% |
| South Carolina, OptumRx | 83% |
| South Dakota, CVS/Caremark | 74% |
| Tennessee, Express Scripts | 73% |
| Texas, Prime Therapeutics | 34% |
| Utah, SelectHealth | 57% |
| Vermont, Express Scripts | 77% |
| Virginia, IngenioRx | 33% |
| Washington, Kaiser Pharmacy | 33% |
| West Virginia, Express Scripts | 75% |
| Wisconsin, MedImpact | 24% |
| Wyoming, Prime Therapeutics | 54% |
The chart is not accessible to screen readers. Please switch to the table view to access the data.
Loading statistic...
Download
Sources
Release date
October 2022
Region
United States
Survey time period
as of October 2022
Citation formats









